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1. Introduction 
Primary malignant melanoma of the esophagus (PMME) accounts for 0.1–0.2% of all 
malignant disease of the esophagus. Ninety-five percent of all melanomas are found in the 
derma, and only 0.5% are localized in the esophagus (Bisceglia et al. 2011). The prognosis of 
PMME is unfavorable because most patients are in the advanced stage at diagnosis and 
rapidly develop lymph node and distant metastases. Nine cases of early-stage PMME have 
been reported in eight papers (Minami et al. 2011; Miyatani et al. 2009; Morita et al. 2009; 
Suzuki et al. 2008; Kimura et al. 2005; Hara et al. 2003; Mikami et al. 2001; Kido et al. 2000). 
Only two of them were treated curatively by endoscopic mucosal resection (EMR) (Miyatani 
et al. 2009; Kimura et al. 2005). We now report on a rare case of multiple early-stage PMME, 
which could obtain prolonged survival for ten years by the combination of systemic 
chemotherapy, repeated endoscopic treatment, and transarterial chemoembolization. 
2. Case report 
A 75-year-old previously healthy man underwent an esophagogastroduodenoscopy (EGD) 
for screening. Three black-pigmented flat lesions were detected in the middle and lower 
thoracic esophagus (Fig. 1), and biopsy specimens revealed features of malignant 
melanoma. The patient refused esophagectomy, and endoscopic mucosal resection (EMR) 
was tried in August 2001. The resected specimen revealed that the tumor had invaded the 
lamina propria (Fig. 2) with no lymphatic or venous invasion and that the horizontal margin 
was positive. The patient again refused esophagectomy and was followed up closely in the 
outpatient clinic. 
Five months after the first EMR, a recurrence was suspected near the EMR scar. The patient 
was referred to our hospital. As an alternative treatment to the esophagectomy, six courses 
of systemic chemotherapy comprising dacarbazine (100 mg/body on day 1, 200 mg/body 
on days 2–5), nimustine hydrochloride (100 mg/body on day 1), and vincristine (1 mg/body 
on day 1) were scheduled every four weeks. However, he was forced to discontinue the  
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Fig. 1. Esophagogastroduodenoscopy showed a black-pigmented flat lesion in the lower 
esophagus. 
 
Fig. 2. A specimen from an endoscopic mucosal resection revealed that the melanoma cells 
had invaded the lamina propria. 
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treatment after four courses of chemotherapy because of severe thrombocytopenia. He then 
underwent an EGD every two or three months, and small black-pigmented spots resembling 
lentigo were detected frequently (Fig. 3). A biopsy specimen revealed the typical histological 
pattern of melanoma, suggesting metachronous multiple lesions. Because no lymph nodes 
were involved and no distant metastasis developed, endoscopic treatment including EMR 
(six times for nine lesions) and tumor ablation using argon plasma coagulation (four times 
for nine lesions) or bipolar coagulation probe (four times for six lesions) were performed 
until June 2009. The pathological diagnoses for all EMR specimens were in situ or 
microinvasive PMME with no lymphatic or venous invasion. Tumor cells were positive for 
melan A and HMB45 according to immunohistochemistry. A representative case of 
microinvasive PMME is shown in Fig. 4A and B. Three specimens of nine lesions resected by 
EMR showed clearly that the black-pigmented area was only part of the whole tumor, and 
the horizontal margin was positive. A representative horizontal-margin-positive case of 
PMME is shown in Fig. 5. 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Small black-pigmented spots resembling lentigo were detected frequently after the 
initial endoscopic treatment. 
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(A) 
 
(B) 
Fig. 4. A specimen from an endoscopic mucosal resection revealed a histological pattern 
typical of microinvasive PMME (A) and was immunohistochemically positive for melan A 
(B). A chromogenic reaction was developed using alkaline phosphatase. 
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Fig. 5. A specimen from an endoscopic mucosal resection showed that the black-pigmented 
area was only part of the whole tumor, and the horizontal margin was positive. 
Seven years after the first diagnosis of PMME, multiple hepatic tumors (in S4, S6, and S8) 
were detected by screening abdominal computed tomography (CT) in December 2007 (Fig. 
6A). To make a definite diagnosis, a liver needle biopsy was performed in April 2008. The 
needle biopsy specimens revealed the same histological pattern of PMME (Fig. 6B) and were 
positive for melan A and HMB45. Then, hepatic metastasis was confirmed. The primary 
lesion was well controlled, and no other distant metastasis was observed. Because the 
patient was too old to reintroduce systemic chemotherapy and the dynamic CT image 
suggested a hypervascular liver tumor, transarterial chemoembolization (TACE) was 
selected. The hepatic metastases gradually progressed even though he received TACE in 
June 2008 and April 2010. He died in August 2011 of hepatic failure because of progression 
of hepatic metastases. The clinical course of this case is summarized in Fig. 7. 
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(A) 
 
(B) 
Fig. 6. (A) Seven years after the first diagnosis, multiple liver tumors were detected by 
screening abdominal computed tomography (arrow in S6). (B) A needle biopsy specimen 
from the liver tumor revealed a histological pattern typical of malignant melanoma. 
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TACE; transarterial chemoembolization 
DAV; dacarbazine, nimustine hydrochloride, and vincristine 
Fig. 7. Clinical course of this case. Local control of multiple early-stage PMME was achieved 
mainly by endoscopic treatment (six endoscopic mucosal resections (EMRs) for nine lesions 
and eight instances of tumor ablation therapy with argon plasma coagulation or a bipolar 
coagulation probe for 15 lesions). 
3. Discussion 
The following diagnostic histological criteria for PMME have been suggested by Allen and 
Spitz (Allen & Spitz. 1953): (1) a typical histological pattern of melanoma and the presence 
of melanin granules within the tumor cells, (2) origin in an area of junctional change within 
the squamous epithelium, and (3) junctional activity with melanotic cells in the adjacent 
epithelium. The melanoma cells were immunohistochemically positive for melan A, HMB45, 
and S-100 protein. These stains are useful for diagnosing amelanotic melanomas in which 
the tumor cells show no evident melanin granules (Fenoglio-Preiser et al. 2008). 
The prognosis of PMME is extremely poor because of its rapid metastatic spread via the 
lymphatic and blood vessels. Early death from widespread metastases is the usual clinical 
course. The average overall survival is only 10–13 months, and only one-third of all patients 
survive for longer than one year after diagnosis (Bisceglia et al. 2011). Surgical resection is 
considered the best method for treating PMME (Adili & Moning 1997; Kato et al. 1991; 
Chalkiadakis et al. 1985; Ludwig et al. 1981). Smaller satellite nodules may present around 
the main tumor, and wider margins of resection are required for treating PMME than with 
other esophageal tumors. However, even if only the patients whom undergone radical 
esophageal resection are analyzed, the five-year survival rate is less than 5% (Simpson et al. 
1990; Sabanathan et al. 1989). Therapeutic options such as radiotherapy, chemotherapy, and 
immunotherapy provide limited benefits, even when used in conjunction with surgery. 
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Table 1 summarizes nine cases of early-stage PMME previously published in the English 
literature. This table demonstrates that PMME has a relatively good prognosis as long as it is 
detected early. However, it remains to be fully elucidated whether these minute lesions are 
true premalignant lesions of advanced PMME. 
 
Case Reference 
Age/ 
Gender 
Location
Macroscopic 
type 
Number of 
lesions 
Depth of 
invasion
Treatment 
Survival/ 
Outcome 
1 
Kido,  
et al. 2000 
60/male lower flat solitary LPMa surgery unknown 
2 
Mikami,  
et al. 2001 
42/female middle polypoid solitary LPM 
surgery+che
motherapy 
2y7me/alive 
3 
Hara,  
et al. 2003 
52/male middle flat solitary EPb 
surgery+che
motherapy 
１y3m/alive 
4 
Kimura,  
et al. 2005 
73/male lower flat solitary EP EMRc 1y3m/alive 
5 
Suzuki,  
et al. 2008 
62/male 
upper to 
middle 
flat solitary EP surgery 2y9m/alive 
6 
 
67/male lower flat solitary LPM surgery 4y5m/alive 
7* 
Morita, 
 et al. 2009 
75/male lower flat multiple LPM 
EMR+chemot
herapy → 
TACEd 
10y/dead 
8 
Miyatani,  
et al. 2009 
64/female lower flat solitary LPM EMR 2y6m/alive 
9 
Minami,  
et al. 2011 
72/male lower flat solitary EP surgery 2y1m/alive 
*The same case of this chapter. 
aLPM, Tumor invades lamina propria muscle; bEP, carcinoma in situ; cEMR, endoscopic mucosal 
resection; dTACE, transarterial chemoembolization for hepatic metastases 
 ey; year, m; month 
Table 1. Features and outcome of early-stage (intramucosal) malignant melanoma of the 
esophagus published in the literaure. 
Endoscopically, PMME lesions appear as intraluminal, polypoid, and (usually, but not 
necessarily) pigmented, irregular masses, which might also be ulcerated. However, only one 
of nine reported cases of early-stage PMME was the polypoid type (Mikami et al. 2001), and 
the other eight cases were all the flat type (Minami et al. 2011; Miyatani et al. 2009; Morita et 
al. 2009; Suzuki et al. 2008; Kimura et al. 2005; Hara et al. 2003; Kido et al. 2000) (Table 1). In 
contrast, no report is available about the flat-type submucosal invasive PMME. In the 
present case, many satellite lesions occurred in separate areas, and all lesions were the flat 
type. In almost 90% of patients, the lesions occur in the middle or distal one-third of the 
esophagus, usually as a solitary tumor, but multiple lesions have been reported in 12% of 
patients (Sabanathan et al. 1989; Joob et al. 1995). To our knowledge, present case is the first 
report of multiple early-stage PMME. 
Especially in cases of the flat-type PMME, it is difficult to accurately define the tumor area 
macroscopically. Because the melanoma cells originated from the basal/deeper layers of the 
epithelium, it is likely that the size of the black-pigmented area depends on the number and 
density of the melanoma cells and does not reflect the true size of the tumor. Narrow-band 
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imaging and/or magnifying endoscopy (Cohen, 2007) were not useful for accurately 
determining the tumor area in the present case (Fig. 8A–C). 
 
(A) 
 
(B) 
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(C) 
Fig. 8. Narrow-band imaging (A), magnifying endoscopy (B), and magnifying endoscopy 
with narrow-band imaging (C) were not useful for accurately determining the tumor area. 
Endoscopic treatment for PMME should be considered for diagnostic purposes (Hirose et al. 
2002) and for treatment purposes in limited cases (Miyatani et al. 2009; Morita et al. 2009; 
Kimura et al. 2005). PMME, especially the polypoid type, can be removed technically by 
endoscopic treatment (Ho et al. 2007; Herman et al. 2001; Xinopoulos et al. 2001; the depth of 
the tumor invasion was not mentioned in these three papers); however, indications for local 
therapy for this disease are still controversial because of the inaccurate diagnosis of the 
tumor area and the possibility of synchronous multiple lesions (Morita et al. 2009; Ho et al. 
2007; Xinopoulos et al. 2001). Further accumulation of early-stage PMME data is required to 
clarify the tumor behavior of this rare disease. 
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